section name header

Evidence summaries

Interventions for Female Pattern Hair Loss

Topical minoxidil appears to be effective in the treatment of female pattern hair loss compared to placebo. Level of evidence: "B"

Comment: The quality of evidence is downgraded by study limitations (unclear allocation concealment and blinding).

Summary

A Cochrane review [Abstract] 1 included 47 studies with a total of 5 290 subjects. The included trials evaluated a wide range of interventions; 17 studies evaluated minoxidil and 3 studies finasteride. The proportion of participants with clinically significant hair regrowth with minoxidil (1% or 2%, follow-up 24 to 32 weeks) at the end of the study was bigger compared with placebo both as self-rated (26.5% versus 13.9%) and investigator-rated (18.4% versus 7.7%) (table T1, moderate quality evidence). There was no difference in effect between the minoxidil 2% and 5% with the quality of evidence rated moderate to low (4 studies, 1006 participants). There was not a difference in adverse events (table T1).

Table 1. Minoxidil (1%, 2% and 5%) compared to placebo for female pattern hair loss

OutcomeRelative effect (95% CI)Risk with placeboRisk with minoxidil (95% CI)Number of participants (studies)
The proportion of participants with self-rated clinically significant hair regrowthRR 1.93 (1.51 to 2.47)139 / 1000268 / 1000 (209 to 343)1148 (6)
Proportion of participants with investigator-rated clinically significant hair regrowthRR 2.35 (1.68 to 3.28)77 / 1000181 / 1000 (129 to 253)1181 (7)
Mean change from baseline in total hair count 3.25 to 20.4 hairs/cm²13.18 hairs/cm²higher (10.92 higher to 15.44 higher)1242 (8)
Adverse eventsRR 1.24 (0.82 to 1.87)88 / 1000109 / 1000 (72 to 164)727 (4)

Finasteride was no more effective than placebo in 3 trials (low quality evidence). Two studies (141 participants) evaluated low-level laser comb therapy compared to a sham device. According to the participants it was not more effective than the sham device. However, there was a difference in favour of low-level laser comb for change from baseline in hair count (MD 17.40, 95% CI 9.74 to 25.06; and MD 17.60, 95% CI 11.97 to 23.23; low quality evidence).

Clinical comments

Note

Date of latest search: 7 July 2015

    References

    • van Zuuren EJ, Fedorowicz Z, Schoones J. Interventions for female pattern hair loss. Cochrane Database Syst Rev 2016;(5):CD007628. [PubMed]

Primary/Secondary Keywords